Publication of Pharmacoeconomic Data Submitted to Reimbursement or Clinical Guidelines Agencies
Technology, Regulations, and Value in Health
Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making
Use of Outcomes Research in Assuring Patient Safety and Quality Care, Second Plenary Session, ISPOR 8th Annual International Meeting, Arlington, VA, USA
Return on Investment of Different Combinations of Bupropion SR Dose and Behavioral Treatment for Smoking Cessation in a Health Care Setting
Medical Care Costs Associated with Postmenopausal Estrogen Plus Progestogen Therapy
Cost-Effectiveness of Interferon Beta-1a, Interferon Beta-1b, and Glatiramer Acetate in Newly Diagnosed Non-primary Progressive Multiple Sclerosis
Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders
Comparing Medications in a Therapeutic Area Using an NNT Model
Portfolio Theory and Cost-Effectiveness Analysis
Comparison of the HUI3 with the SF-36 Preference Based SF-6D in a Clinical Trial Setting
Systematic Assessment of Decision Models in Parkinson's Disease
Estimating Survival for Cost-Effectiveness Analyses